Cardiovascular Effects of Dihydropyridine-Type Calcium Antagonists and Agonists
General Material Designation
[Book]
First Statement of Responsibility
A Fleckenstein
.PUBLICATION, DISTRIBUTION, ETC
Name of Publisher, Distributor, etc.
Berlin Springer Berlin
Date of Publication, Distribution, etc.
2013
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
XIII, 511 Seiten in 1 Teil 229 Figuren, 50 tables XIII, 511 Seiten ., 50 schw.-w. Tabellen 244 x 170 mm
SERIES
Series Title
Bayer-Symposium, 9
CONTENTS NOTE
Text of Note
Welcome.- Calcium Antagonists and Calcium Agonists: Fundamental Criteria and Classification.- With 18 Figures and 5 Tables.- Session I: Ca-Channels.- Mechanism of Calcium Channel Modulation by Dihydropyridine Agonists and Antagonists.- With 12 Figures.- Discussion.- Ca Entry into Vascular Smooth Muscle.- With 11 Figures.- Discussion.- Calcium Currents in Mammalian Central Neurones.- With 3 Figures and 1 Table.- Discussion.- Session II: Molecular Interactions.- Chemistry of Dihydropyridines.- Structure-Function Relationships of 1,4-Dihydropyridines: Ligand and Receptor Perspectives.- With 6 Figures and 2 Tables.- Discussion.- Calcium Channels: Introduction into Their Molecular Pharmacology.- With 15 Figures and 4 Tables.- The Dihydropyridine Receptors.- A Proposed Pharmacological Role for Dihydropyridine Binding Sites in Heart and Coronary Smooth Muscle.- With 21 Figures and 3 Tables.- Discussion.- Session III: Myocardial Effects.- The Effects of 1,4-Dihydropyridine Type Ca2+-Channel Antagonists and Agonists on Intracellular [Ca2+] Transients Accompanying Twitch Contraction of Heart Muscle.- With 5 Figures.- Discussion.- Voltage-Dependent Modulation of Cardiac Ca-Channels by Dihydropyridines.- With 10 Figures.- Discussion.- Effects of the Calcium Agonistic Dihydropyridine Bay K 8644 on the Heart.- With 16 Figures.- Discussion.- Myocardial Effects of Dihydropyridines in Patients.- With 5 Figures and 2 Tables.- Discussion.- Session IV: Effects on Smooth Muscle.- Effect of Dihydropyridines on Visceral Smooth Muscle.- Discussion.- Effects of Ca2+ Antagonists on Isolated Rabbit Mesenteric Resistance Vessels as Compared to Rabbit Aorta.- With 6 Figures and 3 Tables.- Discussion.- Effect of Dihydropyridine Calcium Channel Modulators on Isolated Peripheral and Cerebral Vessels.- With 11 Figures and 1 Table.- Discussion.- Effects of Ca+ +-Agonistic and Ca+ +-Antagonistic 1,4-Dihydropyridine Compounds on Tonic and Phasic Activation of Extramural Coronary Vasculature.- With 14 Figures and 2 Tables.- Discussion.- Effects of Dihydropyridines on Human and Animal Isolated Vessels.- With 10 Figures and 1 Table.- Discussion.- Endothelium-Dependent Vascular Relaxation.- With 2 Figures.- Discussion.- Session V: Circulation.- Coronary and Systemic Hemodynamic Effects of Dihydropyridines.- With 10 Figures and 3 Tables.- Discussion.- Effect of a Dihydropyridine-Type Calcium Antagonist on Cerebral Blood Flow and Metabolism.- With 2 Figures and 4 Tables.- Discussion.- Calcium, Dihydropyridines and Resistance Vessel Tone.- With 1 Figure and 1 Table.- Discussion.- Differences Between Dihydropyridine and Non-Dihydropyridine Calcium Antagonists in Inotropic, Chronotropic, Dromotropic and Vascular Effects: Differences in Underlying Mechanism.- With 6 Figures and 2 Tables.- Discussion.- Effects of Calcium Antagonists on Fixed and Dynamic Obstructions in Patients with Severe Coronary Artery Disease.- With 14 Figures and 5 Tables.- Discussion.- Session VI: Hypertension.- Effects of Calcium Antagonistic and Agonistic Dihydropyridines on Experimental Hypertension and Vascular Damage.- With 7 Figures.- Discussion.- On the Antihypertensive Properties of Nitrendipine, with Observations of Its Effects on Electrolyte Excretion.- With 3 Figures and 5 Tables.- Discussion.- The Use of Calcium Antagonists in the Treatment of Arterial Hypertension.- With 3 Figures.- Discussion.- Calcium Antagonists for Identification of Mechanisms and Treatment in Patients with Essential Hypertension.- With 2 Figures.- Discussion.- Session VII: Tissue Protection.- Dihydropyridines and the Protection of the Ischaemic and Anoxic Myocardium.- With 7 Figures and 4 Tables.- Discussion.- Protection Against Complete Cerebral Ischemia by Nimodipine.- Discussion.- Interdependence of Antihypertensive, Anticalcinotic, and Antiarteriosclerotic Effects of Calcium Antagonists - Model Experiments on Spontaneously Hypertensive Rats (SHR).- With 9 Figures and 2 Tables.- Discussion.